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ABSTRACT The aim of this study was to investigate how many patients 
with atopic dermatitis applied hypoallergenic cosmetics compared 
with topical corticosteroids. The study included 41 patients with atopic 
dermatitis (AD) who were treated from June 1 to July 1, 2017 at the 
Department of Dermatology and Venerology, Clinical Hospital Mostar. 
According to the data analyzed, 46.34% of patients used hypoallergen-
ic cosmetics while 24.39% used them periodically. 32.7% patients used 
topical corticosteroids and 17.07 % used them periodically. 19.51 % 
of the patients with atopic dermatitis used alternative products, while 
17.07% used them periodically. Out of the total number of patients, 
most of the patients used neutral products. 78.05% used neutral cos-
metic products, and 19.51 % used them periodically. 65.85 % patients 
used sunscreens and 24.40 % used them periodically. The majority of 
patients used neutral cosmetic products and sunscreens. There was no 
statistically significant difference in the frequency of the use hypoal-
lergenic cosmetics compared with topical corticosteroids (χ2 = 1.802; 
df = 2; P=0.405). Women used sunscreens more often (χ2 = 16,02; df = 
1; p = <0,05).
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INTRODUCTION
Hypoallergenic cosmetics are a special group of 
cosmetic products in which the formulation of the 
product and the mode of production reduce the risk 
of allergic reactions while still achieving full cosmetic 
effect. Hypoallergenic cosmetics are products that 
manufacturers claim produce fewer allergic reactions 
compared with other cosmetic products and they are 
suitable for people with sensitive skin. These prod-
ucts usually do not have a scent and the formula-
tion is simple without adding unnecessary materials. 
Hypoallergenic creams contain just a third of ingre-
dients that are usually in standard creams, because 
more ingredients mean a greater possibility of side-
effects (1).
The entire production and control of hypoaller-
genic cosmetics must follow the standards of the 
pharmaceutical industry. Each product must have 
instructions for use and a description of the product 
together with its composition, date of manufacture, 
and the expiration date, guaranteeing that the prod-
uct is safe during its period of application (2).
Atopic dermatitis (AD) is a chronic inflammatory 
skin disease caused by genetic predisposition (3). It is 
characterized by itching, dry skin, inflammation, and 
a typical clinical picture, depending on the patient’s 
age which is often associated with other atopic dis-
eases. Atopic dermatitis is a disease with high prev-
alence (4). There are two types of AD: the “intrinsic” 
type of AD (non-allergic form) that is not associated 
with other atopic diseases and allergic (“extrinsic”) 
atopic eczema/dermatitis syndrome (AEDS) which is 
associated with IgE (5).
It is estimated that about 2% of population has 
AD (6). The last decade has seen an increase in the 
number of patients with AD in Europe, and it is esti-
mated that the prevalence is 20% (7). 
Various environmental factors affect the clinical 
expression of AD: allergens, irritants, climatic and 
geographical conditions, bodily constitution, psycho-
logical stress, and secondary infections (8).
The clinical presentation varies from mild to se-
vere. Skin changes can be acute and chronic. The 
lichenification (ashen, brown, or gray patches with 
flat papules), thickened areas in the ribs, neck, and 
eyelids, and chronic facial edema are usually seen in 
the chronic stage of the disease (9). Generally, acute 
lesions are characterized by intense itching with ery-
thematous papules, followed by excoriations, ero-
sions, and serous exudate. Patients often experience 
all three stages of skin changes. Itching is also an im-
portant factor in the emergence of typical eczema in 
these patients (10).
Although there is currently no cure for AD, there 
are different types of interventions which help con-
trol symptoms. The treatment consists of proper skin 
hydration, avoidance of exposure to allergens, using 
topical anti-inflammatory drugs, antihistamines, and 
antibiotics. The goal of the treatment is to prevent 
the formation of dry skin, alleviate itching, prevent 
complications, and simultaneously apply treatment 
creams (corticosteroids, antibiotics, immunomodula-
tors, and antihistamines) on changed skin. 
Most commonly used medications are local corti-
costeroids in the form of fat or cream which have anti-
inflammatory activity and also alleviate itching (11).
Systemic immunosuppressants are used in resis-
tant forms, local immunomodulators in mild atopic 
dermatitis, and one of the new forms of treatment 
involves exposure to ultraviolet (UV) light (12,13).
The aim of this study was to examine how many 
patients with AD applied hypoallergenic cosmetics 
compared WITH topical corticosteroids
MATERIALS AND METHODS
Study population
The study included 41 patients who were treated 
from July 1 to June 1 2017, at the Department of Der-
matology and Venerology, Clinical Hospital Mostar.
The mean age of all included patients was 36.02 
(Standard Deviation (SD) = 20.08). Age is expressed 
as mean and standard deviation. The mean age for 
men was 32.11 (SD=23.83), and for women the mean 
age was 37.13 (SD=20.15). The youngest male patient 
was 1 year old and the oldest was 73 years old. The 
youngest female patient was 8 years old and the old-
est female patient was 80 years old. 
The age of patients was well-balanced between 
sexes and there was no statistically significant differ-
ence in the age to sex balance (Student`s t test t = 
-0.634, df=39, P=0.53). 
Of 41 patients, 9 (22%) were men and 32 (78%) 
were women. There was a statistically significant dif-
ference in patient sex (χ2=12.902, df=1, P<0.05).
Test materials
The data were collected using a questionnaire. It 
consisted of questions about usage of hypoallergen-
ic emollients and washing products, corticosteroids, 
and alternative therapy in patients with atopic dis-
ease. It was completed by patients while they were 
on examination at Department of Dermatology and 
Venerology, Clinical Hospital Mostar. 
Statistical analysis
All data collection was stored in MS Excel 11.0 (Mi-
crosoft Corporation, Redmond WA, USA). SPSS 23.0 
(SPSS, Chicago, IL, USA) was used on statistical analy-
ses. Frequency distributions and percentages were 
used to describe categorical variables. Descriptive 
statistics were used for continuous variables (mean 
and standard deviation). Chi-square test was used for 
quantitative analysis. 
RESULTS
The study included 41 patients with atopic derma-
titis. Table 1 shows usage of different types of cosmet-
ic products among patients with atopic dermatitis. 
46.34% patients used hypoallergenic cosmetics 
and 24.39% patients who used them periodically. 
Out of total number of patients, 29.27% did not use 
hypoallergenic cosmetics at all.
31.70% patients used topical corticosteroids and 
17.07% used them periodically. Most of the patients 
(51.22%) did not use topical corticosteroids at all.
19.51% patients used alternative products and 
17.07% patients used them periodically. Most of the pa-
tients (63.42%) did not use alternative products at all.
Out of total number of patients, most of the pa-
tients used neutral products. 78.05% used neutral 
cosmetic products and 19.51% used them periodi-
cally. Only 2.44% did not use neutral cosmetic prod-
ucts at all.
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65.85% patients used sunscreens and 24.40% 
used them periodically. 9.75 % patients did not use 
sunscreens at all. 
The majority of patients used neutral cosmetic 
products and sunscreens.
There was no statistically significant difference in 
frequency of use of hypoallergenic cosmetics com-
pared with topical corticosteroids (χ2=1.802; df=2; 
P=0.405).
DISCUSSION
This study included 41 patients with atopic derma-
titis. Out of the total number of patients, there were 32 
women and 9 men. There was a statistically significant 
difference between groups according to sex. Addition-
ally, this study showed there was a difference in preva-
lence of atopic dermatitis according to sex. Other stud-
ies also showed higher prevalence of atopic dermatitis 
among men (7). This study showed higher prevalence 
of atopic dermatitis among women, but there were 
more women who participated in the study.   
The prevalence of atopic dermatitis has increased 
by 3-4 times over the last three decades (14). This 
study was carried out to investigate the frequency of 
Table 1. Usage of different types of cosmetic 
products among patients with atopic dermatitis






Hypoallergenic cosmetics 46.34 29.27 24.39
Topical corticosteroids 31.71 51.22 17.07
Alternative products 19.51 63.42 17.07
Neutral cosmetic products 78.05 2.44 19.51
Sunscreens 65.85 9.75 24.40
Table 2. Answers about using different types of products in patients with atopic dermatitis according to 
sex
Type of product Answer
Sex YES NO Periodically χ2
Hypoallergenic cosmetics
(emollients and washing products)
Male 1 (2.44%) 6 (14.63%) 2 (4.88%)
P=0.309
Female 11 (26.83%) 13 (31.70%) 8 (19.51%)
Topical corticosteroids
Male 2 (4.88%) 4 (9.76%) 3 (7.32%)
P=0.864
Female 5 (12.20%) 17 (41.46%) 10 (24.39%)
Alternative products
Male 2 (4.88%) 6 (14.63%) 1 (2.44%)
P=0.860
Female 6 (14.63%) 20 (48.78%) 6 (14.63%)
Neutral cosmetic products
Male 8 (19.51%) 0 (0.00%) 1 (2.44%)
P=0.647
Female 24 (58.54%) 1 (2.44%) 7 (17.07%)
Sunscreen
Male 5 (12.19%) 3 (7.32%) 1 (2.44%)
P=0.022
Female 22 (53.66%) 1 (2.44%) 9 (21.95%)
There was a statistically significant difference in the usage of sunscreens: women used sunscreens more often (χ2 
=16,02; df=1; P<0.05).
the use of hypoallergenic cosmetics among people 
with atopic dermatitis at the Department of Derma-
tology and Venerology, Clinical Hospital Mostar.
Research has shown that atopic dermatitis occurs 
at all ages (1-80 years). The mean age of our sample 
was 36 years. Previous studies showed that atopic 
dermatitis is common among the young population. 
Most of the patients used neutral cosmetic prod-
ucts and sunscreens. A significant number of patients 
also used hypoallergenic cosmetics. Newer studies 
showed that continuous use of hypoallergenic cos-
metics has anti-inflammatory and anti-irritative ef-
fects on the skin, prevents adhesion of Staphylococ-
cus aureus, regenerates hydrolipid film, and alleviates 
dryness of the skin and itching. Usage of hypoaller-
genic cosmetics is useful for prevention of exacerba-
tion, progression, and treatment of atopic dermatitis 
(15). 
There was no statistically significant difference in 
the frequency of usage of hypoallergenic cosmetics 
compared to topical corticosteroids. Topical cortico-
steroids are often used and applied in the acute stage 
of the disease when it is the only effective treatment 
of choice. Topical steroids have some side-effects, so 
it is very important for patients with atopic dermatitis 
to know how to use them properly. There is a term 
“steroid phobia” which denotes the fear of using ste-
roids. Patients with steroid phobia do not use pre-
scribed medical treatment with local corticosteroids 
for unjustified reasons. Many parents or patients 
have steroid phobia and are not willing to use corti-
costeroids even for severe forms of atopic dermatitis, 
which is certainly the result of a misconception, be-
cause under the supervision of a doctor it is the only 
correct choice of therapy.
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There was a statistically significant difference in 
the use of sunscreens. Sunscreens are statistically 
significantly more commonly used by women, but it 
should be taken into consideration that this study in-
cluded more female patients.
Proper exposure to sunlight is important for the 
skin care of patients with atopic dermatitis. In addi-
tion to mechanical protection, products with high 
protective mineral factors should be used daily to 
avoid burns, skin dryness, and the appearance of in-
flammatory skin lesions.
Treatment of atopic dermatitis still remains a 
highly responsible, difficult, and demanding job to-
day, which is why physicians have to increase patient 
compliance by adjusting the treatment to the patient 
and prompting them to regularly apply the appropri-
ate therapy and follow skin care instructions. Regular 
skin care with hypoallergenic products in patients 
with atopic dermatitis is effective not only in preven-
tion but also during systemic therapy (16).
This study had its limitations. Only a small number 
of patients were involved in the study. In future re-
search, it would be interesting to involve a larger num-
ber of patients. Future work should involve a greater 
number of patients under the age of 15, which would 
give even more credible data, since atopic dermatitis 
is most common at earlier ages.
CONCLUSION
Patients with atopic dermatitis who were includ-
ed in this study mostly used neutral cosmetic prod-
ucts and sunscreens. Most of the patients also used 
hypoallergenic cosmetics. Women used sunscreens 
more often. There was no statistically significant dif-
ference in the use of hypoallergenic cosmetics and 
topical corticosteroids. 
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